Join
Live feed
·
INSIDERFilingvia Quantisnow
NeuroOne Medical Technologies Corporation logo

Business Development Director Christianson Mark sold $22,203 worth of shares (30,000 units at $0.74), decreasing direct ownership by 11% to 231,238 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
NMTC· NeuroOne Medical Technologies Corporation
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NMTC (NeuroOne Medical Technologies Corporation) and more on Quantisnow.

Business Development Director Christianson Mark sold $22,203 worth of shares (30,000 units at $0.74), decreasing direct ownership by 11% to 231,238 units (SEC Form 4) | Quantisnow